Characterizing the patient cohort by specific choice of OAT, we noted that the patient cohort prescribed dabigatran was on average younger, had less comorbidities and a higher rate of prior independence, but these differences did not reach statistical significance in our patient sample ( Table S1 ).
← all excerpts
Adherence to oral anticoagulant therapy in secondary stroke prevention - impact of the novel oral anticoagulants.
1
—
—